Splicing machinery is impaired in rheumatoid arthritis, associated with disease activity and modulated by anti-TNF therapy
Open Access
- 8 October 2021
- journal article
- research article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 81 (1), 56-67
- https://doi.org/10.1136/annrheumdis-2021-220308
Abstract
Objectives To characterise splicing machinery (SM) alterations in leucocytes of patients with rheumatoid arthritis (RA), and to assess its influence on their clinical profile and therapeutic response. Methods Leucocyte subtypes from 129 patients with RA and 29 healthy donors (HD) were purified, and 45 selected SM elements (SME) were evaluated by quantitative PCR-array based on microfluidic technology (Fluidigm). Modulation by anti-tumour necrosis factor (TNF) therapy and underlying regulatory mechanisms were assessed. Results An altered expression of several SME was found in RA leucocytes. Eight elements (SNRNP70, SNRNP200, U2AF2, RNU4ATAC, RBM3, RBM17, KHDRBS1 and SRSF10) were equally altered in all leucocytes subtypes. Logistic regressions revealed that this signature might: discriminate RA and HD, and anti-citrullinated protein antibodies (ACPAs) positivity; classify high-disease activity (disease activity score-28 (DAS28) >5.1); recognise radiological involvement; and identify patients showing atheroma plaques. Furthermore, this signature was altered in RA synovial fluid and ankle joints of K/BxN-arthritic mice. An available RNA-seq data set enabled to validate data and identified distinctive splicing events and splicing variants among patients with RA expressing high and low SME levels. 3 and 6 months anti-TNF therapy reversed their expression in parallel to the reduction of the inflammatory profile. In vitro, ACPAs modulated SME, at least partially, by Fc Receptor (FcR)-dependent mechanisms. Key inflammatory cytokines further altered SME. Lastly, induced SNRNP70-overexpression and KHDRBS1-overexpression reversed inflammation in lymphocytes, NETosis in neutrophils and adhesion in RA monocytes and influenced activity of RA synovial fibroblasts. Conclusions Overall, we have characterised for the first time a signature comprising eight dysregulated SME in RA leucocytes from both peripheral blood and synovial fluid, linked to disease pathophysiology, modulated by ACPAs and reversed by anti-TNF therapy.Funding Information
- Postdoctoral Juan de la Cierva Program (FJCI‐2016‐30825)
- Spanish Inflammatory and Rheumatic Diseases Network (RIER), Instituto de Salud Carlos III (RD16/0012/0015)
- Instituto de Salud Carlos III (CD19/00255, PI18/00837)
- Andalusian Regional Health System (PI‐0285‐2017)
This publication has 53 references indexed in Scilit:
- Mitogen-Activated Protein Kinase Phosphorylation of Splicing Factor 45 (SPF45) Regulates SPF45 Alternative Splicing Site Utilization, Proliferation, and Cell AdhesionMolecular and Cellular Biology, 2012
- PTPN22.6, a Dominant Negative Isoform of PTPN22 and Potential Biomarker of Rheumatoid ArthritisPLOS ONE, 2012
- The Pathogenesis of Rheumatoid ArthritisThe New England Journal of Medicine, 2011
- Association of TALS Developmental Disorder with Defect in Minor Splicing Component U4atac snRNAScience, 2011
- Mutations in U4atac snRNA, a Component of the Minor Spliceosome, in the Developmental Disorder MOPD IScience, 2011
- Matrix metalloproteinase-8 deficiency increases joint inflammation and bone erosion in the K/BxN serum-transfer arthritis modelArthritis Research & Therapy, 2010
- Anti-citrullinated collagen type I antibody is a target of autoimmunity in rheumatoid arthritisBiochemical and Biophysical Research Communications, 2005
- Alternatively spliced EDA‐containing fibronectin in synovial fluid as a predictor of rheumatoid joint destructionRheumatology, 2001
- Development and validation of the european league against rheumatism response criteria for rheumatoid arthritis: Comparison with the preliminary american college of rheumatology and the world health organization/international league against rheumatism criteriaArthritis & Rheumatism, 1996
- Expression and functional significance of alternatively spliced CS1 fibronectin in rheumatoid arthritis microvasculature.JCI Insight, 1994